Honeywell Aerospace lands an analyst endorsement ahead of its debut. This is our plan for the stock

Semiconductor stocks were lower after a report that OpenAI may delay its IPO until 2027, adding caution to the AI trade. Nike rose modestly despite downgrades from KeyBanc and Evercore ahead of next week's earnings, with analysts citing ongoing weakness in China and a potentially slower recovery. Honeywell traded lower ahead of Monday's aerospace spin-off, while RBC initiated Honeywell Aerospace at a buy-equivalent rating with a $300 target, implying roughly 35% upside from the expected $220 opening price.

Analysis

The market is signaling a modest de-risking of the AI complex, but the setup looks more like a sentiment air pocket than a fundamental reset. If the private-market IPO window for OpenAI is pushed out, the second-order hit is to near-term monetization narratives for the hardware stack: investors will be slower to underwrite the next wave of hyperscale capex until there is clearer evidence that model demand translates into durable enterprise cash flow. That matters most for names already priced for perpetual AI spend, where even a small delay in the “build-out to payback” cycle can compress multiples before it changes earnings estimates.

Within semis, the weakness is likely to be uneven. The highest-duration AI beneficiaries are most exposed to a narrative fade, while more diversified suppliers with networking, custom silicon, and infrastructure adjacency should prove stickier once the market distinguishes between speculative AI enthusiasm and contracted demand. A near-term bounce is possible if management teams use upcoming commentary to re-anchor capex visibility, but the risk window is the next 2-6 weeks: if guidance merely confirms strong orders without raising FY/next-year revenue conversion, the group can continue to lag broader indices.

Nike remains a classic “show-me” setup with the real issue being not a single quarter but whether management can change the rate of inventory, margin, and regional execution cleanup over the next two reporting cycles. The board-level finance change is directionally positive because it increases the odds of sharper operating discipline, but that also means the turnaround may look worse before it looks better if the company takes more aggressive resets. Contrarianly, the market may be underestimating how much of the bear case is already in the stock; if China stabilizes even modestly and wholesale reacceleration appears, the stock could re-rate quickly because expectations are low and positioning is likely light.

Key Decisions for Investors

• Reduce near-term beta in the AI basket by trimming ARM/NVDA and re-allocating toward AVGO on a 2-6 week horizon; AVGO’s diversified revenue mix should be less vulnerable if AI capex sentiment softens again. Favor a relative long AVGO / short NVDA spread if AI narrative volatility persists.
• Use any further weakness in INTC as a tactical long only if you want a laggard AI/edge inference recovery trade; otherwise avoid the name until management proves capex conversion. Risk/reward is better expressed through a basket long/short than outright exposure.
• Stay patient on NKE, but only via a defined-risk position: buy a small starter long into earnings with a stop on any guidance reset, or sell downside puts for the next quarter. The thesis is that expectations are low enough for a 10-15% squeeze if execution is merely less bad.
• Build HON post-spin, but prefer the new aerospace entity on first-week dislocation rather than the parent. Best expression: accumulate the standalone aerospace stock on opening weakness over 1-3 weeks, targeting a 12-18 month rerating versus defense/aerospace peers.
• If overall market risk appetite improves, consider a short-duration call spread on ARM into any AI rebound, but keep size small: the stock is most exposed to multiple compression if the market decides the OpenAI/IPO delay is a broader signal for slower AI monetization.